{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:24Z","timestamp":1759334844757,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007927","name":"University of Oklahoma Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jaad.2009.09.045","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T04:58:51Z","timestamp":1274504331000},"page":"773-778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Yaohan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Foshee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Sontheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.09.045_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","volume":"66","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2009.09.045_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","article-title":"Rituximab in refractory autoimmune bullous diseases","volume":"31","author":"Schmidt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","article-title":"Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases","volume":"6","author":"Hertl","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2009.09.045_bib4","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.09.045_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-007-0027-6","article-title":"Autoimmunity to type VII collagen: epidermolysis bullosa acquisita","volume":"33","author":"Woodley","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2009.09.045_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.09.045_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature","volume":"143","author":"Cianchini","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archderm.142.2.147","article-title":"Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab","volume":"142","author":"Schmidt","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archderm.143.2.192","article-title":"Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)","volume":"143","author":"Niedermeier","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2133.2006.07596.x","article-title":"A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita","volume":"156","author":"Crichlow","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib11","first-page":"731","article-title":"Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab","volume":"6","author":"Taverna","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1365-2133.2008.08753.x","article-title":"Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180","volume":"159","author":"Daito","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0190-9622(93)70016-M","article-title":"Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa?","volume":"28","author":"Joly","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archderm.1991.01680030111016","article-title":"Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid","volume":"127","author":"Kurzhals","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib15","first-page":"464","article-title":"Acquired localized epidermolysis bullosa: a case with scalp involvement and immunoelectron microscopic study [French]","volume":"120","author":"Karpouzis","year":"1993","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.09.045_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000086445","article-title":"A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis","volume":"211","author":"Osawa","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.09.045_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-4632.2007.03388.x","article-title":"A mixed immunoblistering disorder exhibiting features of bullous pemphigoid and pemphigus foliaceus associated with Spirulina algae intake","volume":"47","author":"Kraigher","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000051661","article-title":"Dual diagnosis of pemphigus and pemphigoid: retrospective review of thirty cases in the literature","volume":"202","author":"Sami","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.09.045_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/clim.2001.5065","article-title":"Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodies","volume":"100","author":"Sami","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2009.09.045_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1399-0039.2006.00677.x","article-title":"Antigen mimicry, epitope spreading and the pathogenesis of pemphigus","volume":"68","author":"Tchernev","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaad.2009.09.045_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.1998.tb01208.x","article-title":"The functional significance of epitope spreading and its regulation by co-stimulatory molecules","volume":"164","author":"Vanderlugt","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaad.2009.09.045_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clim.2005.07.002","article-title":"Epitope spreading within lupus-associated ribonucleoprotein antigens","volume":"117","author":"Deshmukh","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2009.09.045_bib23","first-page":"169","article-title":"Antigen processing by autoreactive B cells promotes determinant spreading","volume":"2","author":"Dai","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaad.2009.09.045_bib24","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1038\/jid.2008.172","article-title":"Rituximab exerts a dual effect in pemphigus vulgaris","volume":"128","author":"Eming","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.09.045_bib25","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/jid.2008.178","article-title":"B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209012602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209012602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:20:18Z","timestamp":1759270818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209012602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0190962209012602"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.09.045","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}